Ananya Das Associate Professor, Department of Obstetrics and Gynecology, North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences, Shillong 793018, Meghalaya, India
Subrat Panda Additional Professor, Department of Obstetrics and Gynecology,North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences, Shillong 793018, Meghalaya, India
Anusuya Sarma Senior Resident, Department of Obstetrics and Gynecology, North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences, Shillong 793018, Meghalaya, India
Biswajit Dey Assistant Professor, Department of Pathology, North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences, Shillong 793018, Meghalaya, India
Address for correspondence: Ananya Das, Associate Professor, Department of Obstetrics and Gynecology, North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences, Shillong 793018, Meghalaya, India E-mail: mailmedrananyadas@rediffmail.com
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
Received : March 10, 2022
Accepted : April 12, 2022
Published : December 25, 2022
Abstract
Sarcomas are connective tissue cancers and Rhabdomyosarcomas are cancers originating from the skeletal muscle cells of the body. A 23 year old female unmarried, nulligravida presented in our emergency with the complaint of bleeding per vagina on and off since last 4 months. The lesion measured 9.2 (cc) x8.7 (cs)x7.8 (ap) cm. The lesion displaced the uterus superiorly distended the vaginal canal compressed the urinary bladder and urethra anteriorly but with no evidence of infiltration into the pelvic side wall and with maintained fat plane. Rest all pelvic organs as well as abdominal organs were within normal limit. The HPE report on microscopic examination of the tissue showed features suggestive of malignant spindle cell neoplasm. Immunohistochemistry was done and IHC report showed: Positive for Desmin, Myogenin predominantly cytoplasmic positive. Correlating the morphologic and IHC markers the report came to be Embryonal Rhabdomyosarcoma (Botryoid Rhabdomyosarcoma). As soon as the final diagnosis was made patient was referred to Department of Oncology and chemotherapy with Cyclophosphamide was started. She has been on regular follow up since then and is keeping well. The presence of a cervical polyp in an adolescent is a gynecologic oddity and must necessarily be examined histologically because it might be a rhabdomyosarcoma. This is extremely important because diagnosis at an early stage of the disease is a highly favorable prognostic factor.
References
1. What Is Rhabdomyosarcoma? [Internet]. [cited 2022 Feb 1]. Available from: https://www.cancer.org/cancer/rhabdomyosarcoma/about/what-isrhabdomyosarcoma.html.
2. Khosla. Adult rhabdomyosarcoma: Clinical presentation, treatment, and outcome [Internet]. [cited 2021 Aug 2]. Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2015;volume=11;issue=4;spage=830;epage=834;aulast=Khosla.
3. Parham DM, Barr FG. Classification of Rhabdomyosarcoma and Its Molecular Basis. Adv Anat Pathol. 2013 Nov;20(6):387–97.
4. Bell J, Averette H, Davis J, Toledano S. Genital rhabdomyosarcoma: current management and review of the literature. ObstetGynecolSurv. 1986 May;41(5):257–63.
5. Atlante M, Dionisi B, Cioni M, Di Ruzza D, Sedati P, Mariani L. Sarcoma botryoides of the uterine cervix in a young woman: a case report. Eur J Gynaecol Oncol. 2000;21(5):504–6.
6. Bernal KL, Fahmy L, Remmenga S, Bridge J, Baker J. Embryonal rhabdomyosarcoma (sarcoma botryoides) of the cervix presenting as a cervical polyp treated with fertility-sparing surgery and adjuvant chemotherapy. Gynecol Oncol. 2004 Oct 1;95(1):243–6.
7. Daya DA, Scully RE. Sarcoma botryoides of the uterine cervix in young women: A clinicopathological study of 13 cases. Gynecol Oncol. 1988 Mar 1;29(3):290–304.
8. Montag TW, D’ablaing G, Schlaerth JB, Gaddis O, Morrow CP. Embryonal rhabdomyosarcoma of the uterine corpus and cervix. Gynecol Oncol. 1986 Oct 1;25(2):171–94.
9. Kriseman ML, Wang W-L, Sullinger J, Schmeler KM, Ramirez PT, Herzog CE, et al. Rhabdomyosarcoma of the Cervix in Adult Women and Younger Patients. Gynecol Oncol. 2012 Sep;126(3):351–6.
10. McClean GE, Kurian S, Walter N, Kekre A, McCluggage WG. Cervical embryonal rhabdomyosarcoma and ovarian Sertoli-Leydig cell tumour: a more than coincidental association of two rare neoplasms? J Clin Pathol. 2007 Mar;60(3):326–8.
11. Golbang P, Khan A, Scurry J, MacIsaac I, Planner R. Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor. Gynecol Oncol. 1997 Oct;67(1):102–6.
12. Dehner LP, Jarzembowski JA, Hill DA. Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations. Mod Pathol Off J U S Can AcadPathol Inc. 2012 Apr;25(4):602–14.
13. Risk Factors for Rhabdomyosarcoma [Internet]. [cited 2021 Aug 5]. Available from: https://www.cancer.org/cancer/rhabdomyosarcoma/causesrisks-prevention/risk-factors.html.
14. Rhabdomyosarcoma Stages and Risk Groups [Internet]. [cited 2021 Aug 5]. Available from: https://www.cancer.org/cancer/rhabdomyosarcoma/detection-diagnosis-staging/staging.html.
15. Nasioudis D, Alevizakos M, Chapman-Davis E, Witkin SS, Holcomb K. Rhabdomyosarcoma of the lower female genital tract: an analysis of 144 cases. Arch Gynecol Obstet. 2017 Aug;296(2):327–34.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.